Caribou Biosciences (CRBU) Tax Rate (2020 - 2021)
Caribou Biosciences' (CRBU) quarterly Tax Rate came in at 1.77% in Q4 2021, down 412.0% year-on-year from 0.57% in Q4 2020, and down 175.19% on a QoQ basis from 2.35% in Q4 2020.
Caribou Biosciences (CRBU) Tax Rate (2020 - 2021) Analysis & Trends
Caribou Biosciences (CRBU) has 2 years of Tax Rate data on file, last reported at 1.77% in Q4 2021.
- On a quarterly basis, Tax Rate fell 412.0% year-over-year to 1.77% in Q4 2021; TTM through Dec 2021 was 0.48%, a 552.0% decrease from a year earlier, with the FY2025 full-year figure at 0.37%, up 36.0% from the prior year.
- Tax Rate for Q4 2021 stood at 1.77%, down from 2.35% in the prior quarter.
- Over the last five years, Tax Rate for CRBU reached as high as 10.93% in Q1 2020 and fell as low as 1.77% in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.29% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -5.41% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 17.68% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 12.51% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 33.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Caribou Biosciences | 156.25 Mn | 38.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -1.77% |
| Dec 31, 2021 | -1.77% |
| Dec 31, 2021 | -1.77% |
| Dec 31, 2020 | 2.35% |
| Dec 31, 2020 | 2.35% |
| Dec 31, 2020 | 2.35% |
| Sep 30, 2020 | 2.61% |
| Sep 30, 2020 | 2.61% |
| Sep 30, 2020 | 2.61% |
| Jun 30, 2020 | 2.60% |
| Jun 30, 2020 | 2.60% |
| Jun 30, 2020 | 2.60% |
| Mar 31, 2020 | 10.93% |
| Mar 31, 2020 | 10.93% |
| Mar 31, 2020 | 10.93% |